scholarly journals Efficacy and Safety of Canagliflozin, a Sodium–Glucose Cotransporter 2 Inhibitor, as Add-on to Insulin in Patients With Type 1 Diabetes

Diabetes Care ◽  
2015 ◽  
Vol 38 (12) ◽  
pp. 2258-2265 ◽  
Author(s):  
Robert R. Henry ◽  
Payal Thakkar ◽  
Cindy Tong ◽  
David Polidori ◽  
Maria Alba
Keyword(s):  
Type 1 Diabetes ◽  
Efficacy And Safety ◽  
Sodium Glucose Cotransporter

Fifty-Two-Week Efficacy and Safety of Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Adults with Type 1 Diabetes (inTandem1)

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 212-OR ◽  
Author(s):  
JOHN B. BUSE ◽  
SATISH K. GARG ◽  
JULIO ROSENSTOCK ◽  
TIMOTHY S. BAILEY ◽  
PHILLIP L. BANKS ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Sglt2 Inhibitor ◽  
Efficacy And Safety ◽  
Adjunct Therapy

scholarly journals Dapagliflozin as an Adjunct Therapy to Insulin in Patients with Type 1 Diabetes Mellitus: Efficacy and Safety of this Combination

2021 ◽  
Vol 1 (1) ◽  
pp. 12
Author(s):  
Johan H Jendle ◽  
Francisco J Ampudia-Blasco ◽  
Martin Füchtenbusch ◽  
Paolo Pozzilli ◽  
◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Type 1 Diabetes Mellitus ◽  
Efficacy And Safety ◽  
Adjunct Therapy

Sign in / Sign up

Export Citation Format

Share Document